CLINICAL HEARING LTD
Company number 12814594 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
CLINICAL HEARING LTD - Analysis Report
Company Number: 12814594
Analysis Date: 2025-07-20 14:57 UTC
Financial Health Assessment for Clinical Hearing Ltd (as at 31 August 2024)
1. Financial Health Score: B
Explanation:
Clinical Hearing Ltd demonstrates a generally sound financial position with positive net current assets and shareholders' funds that have steadily grown over recent years. The company maintains a healthy buffer of liquid cash relative to its short-term obligations, indicating good short-term financial stability. However, the relatively small scale of operations, minimal fixed assets, and absence of employees suggest a lean business model with limited diversification of financial resources. The absence of an income statement (due to small company exemption) limits full analysis of profitability, so while the company shows stable balance sheet metrics, there is some uncertainty about operational cash flow strength.
2. Key Vital Signs (Core Financial Metrics)
| Metric | 2024 Value | Interpretation |
|---|---|---|
| Cash at Bank | £25,588 | Healthy cash reserves, though reduced from prior year (£42,777), still sufficient to cover liabilities |
| Current Liabilities | £20,127 | Decreased from previous year (£38,883), indicating improved short-term debt management |
| Net Current Assets (Working Capital) | £5,461 | Positive working capital signals ability to meet short-term obligations without liquidity stress |
| Shareholders’ Funds (Equity) | £5,787 | Equity base has increased steadily, showing retained earnings and business growth |
| Fixed Assets (Net Book Value) | £326 | Very low fixed asset base, consistent with a service-oriented business with minimal capital needs |
| Employee Count | Nil | No employees, implying business activity is likely owner-operated or outsourced |
| Account Filing Status | Up to date | No overdue filings, indicating good compliance and governance practices |
3. Diagnosis (What the Financial Data Reveals)
Healthy Cash Flow "Pulse": The company maintains a positive cash balance that comfortably exceeds current liabilities, a sign of healthy liquidity and operational cash flow management. The reduction in cash from 2023 to 2024 is notable but not alarming, possibly reflecting investment or operational spending.
Stable Financial "Heartbeat": Net current assets and shareholders' funds have grown year-on-year, indicating retained profits and prudent financial management. The company is not reliant on external financing to cover immediate expenses, reducing financial vulnerability.
Lean "Body Structure": With negligible fixed assets and no employees, the company operates with minimal overhead and capital expenditure. This suggests a service-based model, consistent with its SIC classification as a specialist medical practice (audiology).
Limited "Muscle Mass": The small scale and low asset base mean the company may have limited capacity to absorb shocks or scale rapidly without additional investment or hiring.
"Symptom" of Limited Disclosure: Absence of a profit and loss statement (due to small company exemption) prevents assessment of profitability, margins, and income volatility, which are critical for full financial health diagnosis.
4. Recommendations (Prescriptions for Financial Wellness)
Enhance Financial Transparency:
Consider preparing and sharing a simplified management accounts or profit and loss analysis internally to better monitor operational profitability and cash flow trends beyond balance sheet metrics.Build Cash Reserves:
Although current liquidity is adequate, rebuilding cash reserves closer to prior year levels will strengthen the company's "immune system" against unexpected expenses or downturns.Monitor and Manage Liabilities:
Continue to carefully manage current liabilities, aiming to reduce them further or extend payment terms to maintain a healthy working capital buffer.Strategic Growth Planning:
Evaluate opportunities for scaling operations—whether through hiring, investment in equipment, or marketing—to strengthen business resilience and increase revenue streams.Risk Management:
Given the lean setup, ensure adequate insurance and contingency plans are in place to mitigate risks inherent in a single-director, single-location specialist practice.Compliance and Governance:
Maintain punctual filing of annual returns and accounts to avoid penalties and maintain stakeholder confidence.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.